Whether in neurology, immunology, rare diseases, or the emerging field of gene therapies, we collaborate closely with patients and key stakeholders to understand the true unmet needs for people living with a wide range of conditions, to be able to leverage new technologies and pioneer innovative solutions. Our scientists collaborate with a diverse range of leading researchers from academia, medical charities and industry to advance science and provide the solutions patients need.
Our UK strategic R&D site focuses on a wide range of immunology therapies. A total of four new drugs have been discovered to date in the UK alone, while a further six antibodies that were created here went on to be developed by our colleagues around the world. We are committed partnering with the NHS and we recognise the importance of collaboration to ensure we can deliver the innovative solutions created here for patients living in the UK.
